RecruitingPhase 3NCT07674654
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Sponsor: Kallyope Inc.
Chalmette, LA · New Orleans, LA · +111 more sites
6 recruiting migraine studies with a site in New Orleans, LA.
Sponsor: Kallyope Inc.
Chalmette, LA · New Orleans, LA · +111 more sites
Sponsor: Pfizer
New Orleans, LA · +55 more sites
Sponsor: Pfizer
New Orleans, LA · Shreveport, LA · +167 more sites
Sponsor: Pfizer
New Orleans, LA · +114 more sites
Sponsor: Children's Hospital Medical Center, Cincinnati
New Orleans, LA · +14 more sites
Sponsor: Kallyope Inc.
Chalmette, LA · New Orleans, LA · +111 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.